Search results with tag "Aflibercept"
Eylea® (aflibercept) Injectable Medication ... - Aetna
www.aetna.comEylea® (aflibercept) Injectable Medication Precertification Request Page 1 of 1 Aetna Precertification Notification . Phone: 1-866-752-7021. FAX: 1-888-267-3277. For Medicare Advantage Part B: (All fields must be completed and legible for Precertification Review.) Please Use Medicare Request Form . Please indicate: Start of treatment, start ...
Eylea, INN-aflibercept Assessment report Procedure No ...
www.ema.europa.euCHMP assessment report EMA/646256/2012 Page 6/83 1. Backgroundinformation on the procedure 1.1. Submission of the dossier The applicant Bayer Pharma AGsubmitted on 31 …
采視明 EYLEA Injection) 醫療科技評估報告
www.nhi.gov.tw采視明 (EYLEA ® Injection) 醫療科技評估報告 (藥物納入全民健康保險給付建議書-藥品專用 ) 資料摘要. 藥品名稱 EYLEA 成分 aflibercept
Assessment report - European Medicines Agency
www.ema.europa.euAflibercept is a recombinant human fusion protein that acts as a high -affinity soluble decoy receptor that can block the VEGF pathway by preferentially binding to vascular endothelial growth factor A
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu2 1. NAME OF THE MEDICINAL PRODUCT ZALTRAP 25 mg/ml concentrate for solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of concentrate for solution for infusion contains 25 mg aflibercept*.